Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY APPLICATION • Overview • Comparison by application • Pharmaceutical and biotechnology companies • Academic institutes and research laboratories • Others • Market opportunity by application PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increasing importance of promotional activities • Emerging economies offering opportunities for growth • Increasing geriatric population driving biomedical research PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bio-Rad Laboratories • F. Hoffmann-La Roche • GENERAL ELECTRIC • Merck • PerkinElmer • Thermo Fisher Scientific • Other prominent vendors PART 15: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Parent market Exhibit 02: Global cell analysis market: Segments Exhibit 03: Market characteristics Exhibit 04: Global cell proliferation kits market: Segments Exhibit 05: Market definition: Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global cell proliferation kits market 2017-2022 ($ millions) Exhibit 09: Global cell proliferation kits market: Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition: Five forces 2017 Exhibit 18: Market condition: Five forces 2022 Exhibit 19: Global cell proliferation kits market: Segmentation by application 2017-2022 (% share) Exhibit 20: Comparison by application Exhibit 21: Global cell proliferation kits market by pharmaceutical and biotechnology companies 2017-2022 ($ millions) Exhibit 22: Factors driving growth of global pharmaceutical and biotechnology market Exhibit 23: Global cell proliferation kits market by pharmaceutical and biotechnology companies: Year-over-year growth 2018-2022 (%) Exhibit 24: Global cell proliferation kits market by academic institutes and research laboratories 2017-2022 ($ millions) Exhibit 25: Global cell proliferation kits market by academic institutes and research laboratories: Year-over-year growth 2018-2022 (%) Exhibit 26: Global cell proliferation kits market by others 2017-2022 ($ millions) Exhibit 27: Global cell proliferation kits market by others: Year-over-year growth 2018-2022 (%) Exhibit 28: Market opportunity by application Exhibit 29: Customer landscape Exhibit 30: Global cell proliferation kits market: Segmentation by geography 2017-2022 (% share) Exhibit 31: Regional comparison Exhibit 32: Cell proliferation kits market in Americas 2017-2022 ($ millions) Exhibit 33: Cell proliferation kits market in Americas: Year-over-year growth 2018-2022 (%) Exhibit 34: Top-three countries in Americas Exhibit 35: Cell proliferation kits market in EMEA 2017-2022 ($ millions) Exhibit 36: Cell proliferation kits market in EMEA: Year-over-year growth 2018-2022 (%) Exhibit 37: Top-three countries in EMEA Exhibit 38: Cell proliferation kits market in APAC 2017-2022 ($ millions) Exhibit 39: Cell proliferation kits market in APAC: Year-over-year growth 2018-2022 (%) Exhibit 40: Top-three countries in APAC Exhibit 41: Market opportunity Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Bio-Rad Laboratories: Overview Exhibit 48: Bio-Rad laboratories: Business segments Exhibit 49: Bio-Rad Laboratories: Organizational developments Exhibit 50: Bio-Rad Laboratories: Geographic focus Exhibit 51: Bio-Rad Laboratories: Segment focus Exhibit 52: Bio-Rad laboratories: Key offerings Exhibit 53: F. Hoffmann-La Roche: Overview Exhibit 54: F. Hoffmann-La Roche: Business segments Exhibit 55: F. Hoffmann-La Roche: Organizational developments Exhibit 56: F. Hoffmann-La Roche: Geographic focus Exhibit 57: F. Hoffmann-La Roche: Segment focus Exhibit 58: F. Hoffmann-La Roche: Key offerings Exhibit 59: GENERAL ELECTRIC: Overview Exhibit 60: GENERAL ELECTRIC: Business segments Exhibit 61: GENERAL ELECTRIC: Organizational developments Exhibit 62: GENERAL ELECTRIC: Geographic focus Exhibit 63: GENERAL ELECTRIC: Segment focus Exhibit 64: GENERAL ELECTRIC: Key offerings Exhibit 65: Merck: Overview Exhibit 66: Merck: Business segments Exhibit 67: Merck: Organizational developments Exhibit 68: Merck: Geographic focus Exhibit 69: Merck: Segment focus Exhibit 70: Merck: Key offerings Exhibit 71: PerkinElmer: Overview Exhibit 72: PerkinElmer: Business segments Exhibit 73: PerkinElmer: Organizational developments Exhibit 74: PerkinElmer: Geographic focus Exhibit 75: PerkinElmer: Segment focus Exhibit 76: PerkinElmer: Key offerings Exhibit 77: Thermo Fisher Scientific: Overview Exhibit 78: Thermo Fisher Scientific: Business segments Exhibit 79: Thermo Fisher Scientific: Organizational developments Exhibit 80: Thermo Fisher Scientific: Geographic focus Exhibit 81: Thermo Fisher Scientific: Segment focus Exhibit 82: Thermo Fisher Scientific: Key offerings

Bio-Rad Laboratories, F. Hoffmann-La Roche, GENERAL ELECTRIC, Merck, PerkinElmer, and Thermo Fisher Scientific.